Search results for "Cardiovascular Disease"


 
Results 31 - 40 of about 405 for "Cardiovascular Disease".
Sort by: Relevance | Newest | Oldest

MKSAP Quiz: Routine office visit for patient with HIV

A 44-year-old man is evaluated in the office during a routine visit. Medical history is significant for HIV diagnosed at age 25 years, hypertension, and hyperlipidemia. He is a current smoker. Following a physical exam, lab tests, and electrocardiogram, what factors will result in underestimation of the risk for atherosclerotic cardiovascular disease in this patient?
https://immattersacp.org/weekly/archives/2018/12/18/3.htm
18 Dec 2018

Why internists should care about lipoprotein(a)

Lipoprotein(a) can be a significant risk factor for heart disease and requires consideration when developing a plan of care, especially in the highest risk patients.
https://immattersacp.org/archives/2020/05/why-internists-should-care-about-lipoproteina.htm
1 May 2020

MKSAP Quiz: Risk assessment in a healthy patient

A 45-year-old man is evaluated during a routine visit. He reports no symptoms, and his medical and family history are unremarkable. Following a physical exam, what is the most appropriate cardiovascular disease assessment?
https://immattersacp.org/weekly/archives/2023/09/05/3.htm
5 Sep 2023

Polypill strategy may help improve outcomes, adherence in underserved populations

The researchers said that the observed reductions in systolic blood pressure and LDL cholesterol level were clinically and statistically significant and, if sustained, would lead to an estimated 25% reduction in cardiovascular event incidence.
https://immattersacp.org/weekly/archives/2019/09/24/2.htm
24 Sep 2019

Some traditional Chinese medicine may provide benefits in cardiovascular conditions

Some traditional Chinese medications might be used as a complementary and alternative approach for primary and secondary prevention of cardiovascular disease, but further long-term study is needed.
https://immattersacp.org/weekly/archives/2017/06/13/2.htm
13 Jun 2017

Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD

The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://immattersacp.org/weekly/archives/2018/12/04/2.htm
4 Dec 2018

Oral fluoroquinolones may not be associated with increased arrhythmia risk

Researchers detected a significant difference according to age group, but no statistically significant differences in rate ratios in subanalyses of underlying cardiovascular disease, co-treatment with drugs known to increase the risk of torsades de points, country of residence, or sex or across levels of arrhythmia risk score.
https://immattersacp.org/weekly/archives/2016/03/08/5.htm
8 Mar 2016

Evidence evolving on aspirin as prevention

Practice-changing points may influence how internists prescribe aspirin for the primary prevention of heart disease.
https://immattersacp.org/archives/2019/03/evidence-evolving-on-aspirin-as-prevention.htm
1 Mar 2019

Updated guideline on cholesterol management focuses on detailed risk assessment

The guideline from the American College of Cardiology/American Heart Association recommends that physicians talk to patients about risk-enhancing factors that can help provide a more personalized risk assessment, in addition to such traditional risk factors as smoking and high blood pressure.
https://immattersacp.org/weekly/archives/2018/11/20/2.htm
20 Nov 2018

LABAs, LAMAs for COPD may be associated with increased CVD risk in first 30 days of use

Study authors caution physicians to closely monitor new users of long-acting beta2-agonists (LABAs) or long-acting antimuscarinic antagonists (LAMAs) for cardiovascular symptoms.
https://immattersacp.org/weekly/archives/2018/01/09/4.htm
9 Jan 2018

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next